Literature DB >> 11578717

The epidemiological features of heart failure in developing countries: a review of the literature.

G F Mendez1, M R Cowie.   

Abstract

Cardiovascular diseases are increasingly recognised as an important cause of morbidity and mortality in developing countries. This is due to the ageing of the population and better control of communicable disease and malnutrition. We review the published data on the epidemiology of heart failure in such countries. Rheumatic heart disease remains a major cause of heart failure in Africa and Asia, especially in the young. Hypertension is an important cause of heart failure especially in the African and African-American population. Chagas' disease is still a cause of heart failure in South America. However, as countries go through epidemiological transition and undergo socio-economic development, the epidemiology of heart failure becomes increasingly similar to that of Western Europe and North America with coronary artery disease being the single most common cause of heart failure. Preventive and public health strategies need to be specific to the local epidemiological characteristics.

Entities:  

Mesh:

Year:  2001        PMID: 11578717     DOI: 10.1016/s0167-5273(01)00497-1

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  45 in total

1.  Heart failure: a global disease requiring a global response.

Authors:  J E Sanderson; T-f Tse
Journal:  Heart       Date:  2003-06       Impact factor: 5.994

Review 2.  Aging and heart failure: changing demographics and implications for therapy in the elderly.

Authors:  Bodh I Jugdutt
Journal:  Heart Fail Rev       Date:  2010-09       Impact factor: 4.214

Review 3.  STEMI and heart failure in the elderly: role of adverse remodeling.

Authors:  Anwar Jelani; Bodh I Jugdutt
Journal:  Heart Fail Rev       Date:  2010-09       Impact factor: 4.214

Review 4.  Cost-effectiveness of cardiac resynchronization therapy plus an implantable cardioverter-defibrillator in patients with heart failure: a systematic review.

Authors:  Abedin Teimourizad; Aziz Rezapour; Saeed Sadeghian; Masih Tajdini
Journal:  Cost Eff Resour Alloc       Date:  2021-05-21

5.  Cancer Antigen 125 is Associated with Length of Stay in Patients with Acute Heart Failure.

Authors:  Hakki Kaya; Recep Kurt; Osman Beton; Ali Zorlu; Hasan Yucel; Hakan Gunes; Didem Oguz; Mehmet Birhan Yilmaz
Journal:  Tex Heart Inst J       Date:  2017-02-01

Review 6.  Clinical epidemiology of heart failure.

Authors:  Arend Mosterd; Arno W Hoes
Journal:  Heart       Date:  2007-09       Impact factor: 5.994

7.  Comprehensive plasma metabolomic and lipidomic analyses reveal potential biomarkers for heart failure.

Authors:  Juntuo Zhou; Xi Chen; Wei Chen; Lijun Zhong; Ming Cui
Journal:  Mol Cell Biochem       Date:  2021-05-11       Impact factor: 3.396

8.  Designing effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registries.

Authors:  Stephen J Greene; Ami N Shah; Javed Butler; Andrew P Ambrosy; Stefan D Anker; Ovidiu Chioncel; Sean P Collins; Wilfried Dinh; Preston M Dunnmon; Gregg C Fonarow; Carolyn S P Lam; Robert J Mentz; Burkert Pieske; Lothar Roessig; Giuseppe M C Rosano; Naoki Sato; Muthiah Vaduganathan; Mihai Gheorghiade
Journal:  Am Heart J       Date:  2014-05-24       Impact factor: 4.749

9.  Markers of Atherosclerosis, Clinical Characteristics, and Treatment Patterns in Heart Failure: A Case-Control Study of Middle-Aged Adult Heart Failure Patients in Rural Kenya.

Authors:  Gerald S Bloomfield; Allison K DeLong; Constantine O Akwanalo; Joseph W Hogan; E Jane Carter; Daniel F Aswa; Cynthia Binanay; Myra Koech; Sylvester Kimaiyo; Eric J Velazquez
Journal:  Glob Heart       Date:  2016-03

10.  Heart Failure Etiologies and Challenges to Care in the Developing World: An Observational Study in the Democratic Republic of Congo.

Authors:  Didier Malamba-Lez; Dophra Ngoy-Nkulu; Paul Steels; Désiré Tshala-Katumbay; Wilfried Mullens
Journal:  J Card Fail       Date:  2018-10-23       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.